BIA
LLY icon

Bigelow Investment Advisors’s Eli Lilly LLY Stock Holding History

Bigelow Investment Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$766K Sell
639
-6
-0.9% -$6.13K 0.28% 89
2026
Q1 		$593K Buy
645
+41
+7% +$41.6K 0.24% 97
2025
Q4 		$649K Sell
604
-48
-7% -$45.9K 0.25% 94
2025
Q3 		$497K Buy
652
+95
+17% +$70.7K 0.2% 115
2025
Q2 		$434K Buy
557
+43
+8% +$33.4K 0.19% 119
2025
Q1 		$425K Buy
+514
New +$428K 0.2% 113

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bigelow Investment Advisors's LLY Position: Q2 2026 in Review

Bigelow Investment Advisors reduced its Eli Lilly (LLY) stake by 0.93% in Q2 2026, selling an estimated $6.13K and leaving 639 shares worth $766K. The position accounts for 0.28% of the portfolio, ranked #89.

Bigelow Investment Advisors first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bigelow Investment Advisors held 639 shares of Eli Lilly worth $766K as of Q2 2026.
  • Bigelow Investment Advisors sold 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
  • Eli Lilly made up 0.28% of Bigelow Investment Advisors's portfolio in Q2 2026, its #89 holding.
  • Bigelow Investment Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bigelow Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.